NEW YORK (GenomeWeb News) — Invitrogen and Viropro have signed an R&D agreement in which Invitrogen will test protein-production techniques and cell-development technology developed by Viropro, Viropro said today.
 
Viropro, based in Montreal, also said the deal allows the company the opportunity to out-license the combined technology and make intellectual property deals with biotech companies looking to integrate the IP into their own research and production processes.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.